We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 12.00 | 0.84% | 1,440.00 | 1,431.00 | 1,433.00 | 1,448.00 | 1,417.00 | 1,439.00 | 207,305 | 16:35:10 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 968.24 | 1.94B |
From May 2019 to May 2024
TIDMINDV
RNS Number : 7286I
Indivior PLC
01 September 2016
Indivior PLC (the 'Company')
Following the announcement on April 7, 2016 of the intention to appoint Lizabeth Zlatkus as independent Non-Executive Director of the Company, the Company today confirms that the effective date of Ms Zlatkus' appointment is September 1, 2016.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLBMJTMBBMBLF
(END) Dow Jones Newswires
September 01, 2016 09:22 ET (13:22 GMT)
1 Year Indivior Chart |
1 Month Indivior Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
